Gliotoxin-mediated suppression of innate and adaptive immune functions directed against Listeria monocytogenes

Medical Mycology

Volumn 44, Issue 7, 2006, Pages 591-599

  Kupfahl, C ^a   Geginat, G ^a   Hof, H ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

Gliotoxin; Immunity; Listeriosis

Indexed keywords

GLIOTOXIN; INTERLEUKIN 12; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL TYPE; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FUNGAL VIRULENCE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; LYMPHOCYTE FUNCTION; MACROPHAGE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN FUNCTION; TARGET CELL DESTRUCTION;

ANIMALS; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL SURVIVAL; GLIOTOXIN; IMMUNITY; IMMUNITY, CELLULAR; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C;

ASPERGILLUS FUMIGATUS; BACTERIA (MICROORGANISMS); FUNGI; LISTERIA MONOCYTOGENES;

EID: 33748640698     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780600815411     Document Type: Article

References (44)

1. Tomee, JF and Kauffman, HF. (2000) Putative virulence factors of Aspergillus fumigatus Clin Exp Allergy, 30, pp. 476-484.
2. Waring, P and Eichner, RD and Mullbacher, A. (1988) The chemistry and biology of the immunomodulating agent gliotoxin and related epipolythiodioxopiperazines Med Res Rev, 8, pp. 499-524.
3. Lewis, RE and Wiederhold, NP and Chi, J and (2005) Detection of gliotoxin in experimental and human aspergillosis Infect Immun, 73, pp. 635-637.
4. Watanabe, A and Kamei, K and Sekine, T and (2003) Immunosuppressive substances in Aspergillus fumigatus culture filtrate J Infect Chemother, 9, pp. 114-121.
5. Tsunawaki, S and Yoshida, LS and Nishida, S and (2004) Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase Infect Immun, 72, pp. 3373-3382.
6. Nishida, S and Yoshida, LS and Shimoyama, T and (2005) Fungal metabolite gliotoxin targets flavocytochrome b558 in the activation of the human neutrophil NADPH oxidase Infect Immun, 73, pp. 235-244.
7. Fitzpatrick, LR and Wang, J and Le, T. (2002) Gliotoxin, an inhibitor of nuclear factor-kappa B, attenuates peptidoglycan-polysaccharide-induced colitis in rats Inflamm Bowel Dis, 8, pp. 159-167.
8. Herfarth, H and Brand, K and Rath, HC and (2000) Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin Clin Exp Immunol, 120, pp. 59-65.
9. Wichmann, G and Herbarth, O and Lehmann, I. (2002) The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells Environ Toxicol, 17, pp. 211-218.
10. Yamada, A and Kataoka, T and Nagai, K. (2000) The fungal metabolite gliotoxin: Immunosuppressive activity on CTL-mediated cytotoxicity Immunol Lett, 71, pp. 27-32.
11. Braithwaite, AW and Eichner, RD and Waring, P and (1987) The immunomodulating agent gliotoxin causes genomic DNA fragmentation Mol Immunol, 24, pp. 47-55.
12. Suen, YK and Fung, KP and Lee, CY and (2001) Gliotoxin induces apoptosis in cultured macrophages via production of reactive oxygen species and cytochrome c release without mitochondrial depolarization Free Radic Res, 35, pp. 1-10.
13. Zhou, X and Zhao, A and Goping, G and (2000) Gliotoxin-induced cytotoxicity proceeds via apoptosis and is mediated by caspases and reactive oxygen species in LLC-PK1 cells Toxicol Sci, 54, pp. 194-202.
14. Barsig, J and Kaufmann, SH. (1997) The mechanism of cell death in Listeria monocytogenes-infected murine macrophages is distinct from apoptosis Infect Immun, 65, pp. 4075-4081.
15. Eichner, RD and Waring, P and Geue, AM and (1988) Gliotoxin causes oxidative damage to plasmid and cellular DNA J Biol Chem, 263, pp. 3772-3777.
16. Pahl, HL and Krauss, B and Schulze-Osthoff, K and (1996) The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB J Exp Med, 183, pp. 1829-1840.
17. Liu, ZG and Hsu, H and Goeddel, DV and (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death Cell, 87, pp. 565-576.
18. Arlt, A and Vorndamm, J and Breitenbroich, M and (2001) Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin Oncogene, 20, pp. 859-868.
19. Baust, H and Schoke, A and Brey, A and (2003) Evidence for radiosensitizing by gliotoxin in HL-60 cells: Implications for a role of NF-kappaB independent mechanisms Oncogene, 22, pp. 8786-8796.
20. Baeuerle, PA and Henkel, T. (1994) Function and activation of NF-kappa B in the immune system Annu Rev Immunol, 12, pp. 141-179.
21. Waring, P and Eichner, RD and Mullbacher, A and (1988) Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties J Biol Chem, 263, pp. 18493-18499.
22. Pamer, EG. (2004) Immune responses to Listeria monocytogenes Nat Rev Immunol, 4, pp. 812-823.
23. Jung, S and Unutmaz, D and Wong, P and (2002) In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens Immunity, 17, pp. 211-220.
24. Hauf, N and Goebel, W and Fiedler, F and (1997) Listeria monocytogenes infection of P388D1 macrophages results in a biphasic NF-kappaB (RelA/ p50) activation induced by lipoteichoic acid and bacterial phospholipases and mediated by IkappaBalpha and IkappaBbeta degradation Proc Natl Acad Sci U S A, 94, pp. 9394-9399.
25. Jones, S and Portnoy, DA. (1994) Characterization of Listeria monocytogenes pathogenesis in a strain expressing perfringolysin O in place of listeriolysin O Infect Immun, 62, pp. 5608-5613.
26. Pamer, EG. (1994) Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope J Immunol, 152, pp. 686-694.
27. Harty, JT and Bevan, MJ. (1992) CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo J Exp Med, 175, pp. 1531-1538.
28. Svensson, M and Stockinger, B and Wick, MJ. (1997) Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells J Immunol, 158, pp. 4229-4236.
29. Skoberne, M and Schenk, S and Hof, H and Geginat, G. (2002) Cross-presentation of Listeria monocytogenes-derived CD4 T cell epitopes J Immunol, 169, pp. 1410-1418.
30. Inaba, K and Inaba, M and Romani, N and (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor J Exp Med, 176, pp. 1693-1702.
31. Green, LC and Wagner, DA and Glogowski, J and (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem, 126, pp. 131-138.
32. Geginat, G and Nichterlein, T and Kretschmar, M and (1999) Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua J Immunol, 162, pp. 4781-4789.
33. Janda, J and Schoneberger, P and Skoberne, M and (2004) Cross-presentation of Listeria-derived CD8 T cell epitopes requires unstable bacterial translation products J Immunol, 173, pp. 5644-5651.
34. Kwok, LY and Lutjen, S and Soltek, S and (2003) The induction and kinetics of antigenspecific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis J Immunol, 170, pp. 1949-1957.
35. Sutton, P and Newcombe, NR and Waring, P and (1994) In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi Infect Immun, 62, pp. 1192-1198.
36. Pasparakis, M and Alexopoulou, L and Episkopou, V and (1996) Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response J Exp Med, 184, pp. 1397-1411.
37. Serbina, NV and Salazar-Mather, TP and Biron, CA and Kuziel, WA and Pamer, EG. (2003) TNF/iNOS producing dendritic cells mediate innate immune defense against bacterial infection Immunity, 19, pp. 59-70.
38. Stanzani, M and Orciuolo, E and Lewis, R and (2005) Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes Blood, 105, pp. 2258-2265.
39. Delhalle, S and Blasius, R and Dicato, M and (2004) A beginner's guide to NFkappaB signaling pathways Ann N Y Acad Sci, 1030, pp. 1-13.
40. Kroll, M and Arenzana-Seisdedos, F and Bachelerie, F and (1999) The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome Chem Biol, 60, pp. 689-698.
41. Rock, KL and Gramm, C and Rothstein, L and (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules Cell, 78, pp. 761-771.
42. MacMicking, J and Xie, QW and Nathan, C. (1997) Nitric oxide and macrophage function Annu Rev Immunol, 15, pp. 323-350.
43. Berke, G. (1994) The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects Annu Rev Immunol, 12, pp. 735-773.
44. Romani, L. (2004) Immunity to fungal infections Nat Rev Immunol, 4, pp. 1-23.